491 related articles for article (PubMed ID: 37601653)
1. Genetics of enzymatic dysfunctions in metabolic disorders and cancer.
Mahé M; Rios-Fuller TJ; Karolin A; Schneider RJ
Front Oncol; 2023; 13():1230934. PubMed ID: 37601653
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma stage: an almost loss of fatty acid metabolism and gain of glucose metabolic pathways dysregulation.
Balakrishnan K
Med Oncol; 2022 Oct; 39(12):247. PubMed ID: 36209296
[TBL] [Abstract][Full Text] [Related]
4. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
Højlund K
Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
[TBL] [Abstract][Full Text] [Related]
5. Insights into the Regulatory Role of Non-coding RNAs in Cancer Metabolism.
Beltrán-Anaya FO; Cedro-Tanda A; Hidalgo-Miranda A; Romero-Cordoba SL
Front Physiol; 2016; 7():342. PubMed ID: 27551267
[TBL] [Abstract][Full Text] [Related]
6. Lipid metabolism in cancer progression and therapeutic strategies.
Fu Y; Zou T; Shen X; Nelson PJ; Li J; Wu C; Yang J; Zheng Y; Bruns C; Zhao Y; Qin L; Dong Q
MedComm (2020); 2021 Mar; 2(1):27-59. PubMed ID: 34766135
[TBL] [Abstract][Full Text] [Related]
7. Lipid Metabolism and Mitochondria: Cross Talk in Cancer.
Srivastava A; Srivastava P; Mathur S; Abbas S; Rai N; Tiwari S; Tiwari M; Sharma L
Curr Drug Targets; 2022; 23(6):606-627. PubMed ID: 34431462
[TBL] [Abstract][Full Text] [Related]
8. Fatty acid oxidation: An emerging facet of metabolic transformation in cancer.
Ma Y; Temkin SM; Hawkridge AM; Guo C; Wang W; Wang XY; Fang X
Cancer Lett; 2018 Oct; 435():92-100. PubMed ID: 30102953
[TBL] [Abstract][Full Text] [Related]
9. Metabolic Reprogramming and Potential Therapeutic Targets in Lymphoma.
Pang Y; Lu T; Xu-Monette ZY; Young KH
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982568
[TBL] [Abstract][Full Text] [Related]
10. Dysregulated metabolic enzymes and metabolic reprogramming in cancer cells.
Sreedhar A; Zhao Y
Biomed Rep; 2018 Jan; 8(1):3-10. PubMed ID: 29399334
[TBL] [Abstract][Full Text] [Related]
11. GADD45B regulates the carcinogenesis process of chronic atrophic gastritis and the metabolic pathways of gastric cancer.
Xu W; Jiang T; Shen K; Zhao D; Zhang M; Zhu W; Liu Y; Xu C
Front Endocrinol (Lausanne); 2023; 14():1224832. PubMed ID: 37608794
[TBL] [Abstract][Full Text] [Related]
12. Participation of protein metabolism in cancer progression and its potential targeting for the management of cancer.
Liu D; Wang Y; Li X; Wang Y; Zhang Z; Wang Z; Zhang X
Amino Acids; 2023 Oct; 55(10):1223-1246. PubMed ID: 37646877
[TBL] [Abstract][Full Text] [Related]
13. Aberrant Lipid Metabolism in Cancer: Current Status and Emerging Therapeutic Perspectives.
Irshad R; Tabassum S; Husain M
Curr Top Med Chem; 2023; 23(12):1090-1103. PubMed ID: 37218199
[TBL] [Abstract][Full Text] [Related]
14. Hyperammonemia in Inherited Metabolic Diseases.
Ribas GS; Lopes FF; Deon M; Vargas CR
Cell Mol Neurobiol; 2022 Nov; 42(8):2593-2610. PubMed ID: 34665389
[TBL] [Abstract][Full Text] [Related]
15. Pheochromocytoma: The First Metabolic Endocrine Cancer.
Jochmanova I; Pacak K
Clin Cancer Res; 2016 Oct; 22(20):5001-5011. PubMed ID: 27742786
[TBL] [Abstract][Full Text] [Related]
16. Role of Glycolytic and Glutamine Metabolism Reprogramming on the Proliferation, Invasion, and Apoptosis Resistance through Modulation of Signaling Pathways in Glioblastoma.
Trejo-Solis C; Silva-Adaya D; Serrano-García N; Magaña-Maldonado R; Jimenez-Farfan D; Ferreira-Guerrero E; Cruz-Salgado A; Castillo-Rodriguez RA
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139462
[TBL] [Abstract][Full Text] [Related]
17. Metabolic Alterations in Cancer Cells and the Emerging Role of Oncometabolites as Drivers of Neoplastic Change.
Zhou Z; Ibekwe E; Chornenkyy Y
Antioxidants (Basel); 2018 Jan; 7(1):. PubMed ID: 29342092
[TBL] [Abstract][Full Text] [Related]
18. Why does tumor-associated fatty acid synthase (oncogenic antigen-519) ignore dietary fatty acids?
Menendez JA; Colomer R; Lupu R
Med Hypotheses; 2005; 64(2):342-9. PubMed ID: 15607569
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs as Regulators of Cancer Cell Energy Metabolism.
Suriya Muthukumaran N; Velusamy P; Akino Mercy CS; Langford D; Natarajaseenivasan K; Shanmughapriya S
J Pers Med; 2022 Aug; 12(8):. PubMed ID: 36013278
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial and metabolic alterations in cancer cells.
Di Gregorio J; Petricca S; Iorio R; Toniato E; Flati V
Eur J Cell Biol; 2022; 101(3):151225. PubMed ID: 35453093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
